EP3069735
Dúókarmýsín ADCS til að nota við að meðhöndla krabbamein í þvagblöðru
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.1.2015EP published:
14.3.2018EP application number:
16160637.1
EP translation filed:
7.5.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
8.1.2035Expiry date:
8.1.2025
Title:
DUOCARMYCIN ADCS FOR USE IN THE TREATMENT OF BLADDER CANCER
Timeline
Today
9.1.2015EP application
14.3.2018EP Publication
7.5.2018Translation submitted
15.6.2018Registration published
8.1.2025Expires
Owner
Name:
Byondis B.V.Address:
Microweg 22, 6545, CM Nijmegen, NL
Inventor
Name:
DOKTER, WillemAddress:
CM Nijmegen, NL
Name:
GOEDINGS, Peter JohannesAddress:
CM Nijmegen, NL
Name:
VERHEIJDEN, Gijsbertus Franciscus MariaAddress:
CM Nijmegen, NL
Name:
BEUSKER, Patrick HenryAddress:
CM Nijmegen, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14150791Date:
10.1.2014Country:
EP
Number:
14188450Date:
10.10.2014Country:
EP
Classification
Categories:
A61P 35/00, A61K 47/50
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 30.1.2019
Expires: 8.1.2020
Payer: Tego ehf.
Number: 6
Paid: 27.1.2020
Expires: 8.1.2021
Payer: Tego ehf.
Number: 7
Paid: 18.12.2020
Expires: 8.1.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.12.2021
Expires: 8.1.2023
Payer: Patice ehf.
Number: 9
Paid: 30.12.2022
Expires: 8.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 20.12.2023
Expires: 8.1.2025
Payer: Árnason Faktor ehf.